Therapies for Hepatitis C Infection: Targeting the Non-Structural Proteins of HCV

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 14, 2 Issues, 2016

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Therapies for Hepatitis C Infection: Targeting the Non-Structural Proteins of HCV

Anti-Infective Agents, 1(2): 163-176.

Author(s): Pierre L. Beaulieu and Montse Llinas-Brunet.

Affiliation: Boehringer Ingelheim (Canada) Ltd., Research and Development, Department of Medicinal Chemistry, 2100 Cunard Street, Laval (Quebec) Canada H7S 2G5


The hepatitis C virus infects an estimated 1-3% of the world population. A large proportion of individuals afflicted by this rapidly spreading epidemic eventually progress to chronic liver disorders. Liver failures associated with chronic hepatitis C infections are the leading cause for liver transplantations in the US. Currently, the backbone of anti-HCV therapy, consisting of various forms of interferon in combination with broad-spectrum antivirals such as ribavirin, has only met with limited success. This review will provide coverage of recent efforts towards the development of novel antiviral strategies that target inhibition of essential enzymatic functions encoded by the non-structural region of the HCV genome. These include principally, inhibition of the NS3 protease and helicase, and of the NS5B RNA-dependent RNA polymerase.


Hepatitis c infection, Non-structural proteins, Hepatitis c virus, Ns3 protease, Benzimidazole-containing inhibitors, Inhibition of ns3 helicase, Ns5b polymerase.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 1
Issue Number: 2
First Page: 163
Last Page: 176
Page Count: 14
DOI: 10.2174/1568012023354983
Price: $58
Superbugs USA

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science